VivoSeq
Other

Dilation

0

Pipeline Programs

1

Active Trials

0

Companies Involved

Dilation is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

11/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

18

clinical trials

Completed10 · 56%
Unknown status5 · 28%
Terminated2 · 11%
Active, not recruiting1 · 6%

Trial Activity

18 trials

CF Bronchodilation
Active, not recruiting·UUniversity of British Columbia·N/A·NCT03522831·20 enrolled
Pre-Op Sildosine and Ureteral Dilation During F-URS
Completed··N/A·NCT05798572·140 enrolled
Evaluation of Pupil Dilation Speed With the MAP Dispenser
Completed·EEyenovia Inc.·Phase 4·NCT04907474·61 enrolled
Exploration of Pupil Dilation in Horner's Patients Taking Flomax
Terminated··Phase 4·NCT03615508·1 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)